about
Antineoplastic agents and thrombotic microangiopathy.Thrombotic Microangiopathy Following Chemotherapy with S-1 and Cisplatin in a Patient with Gastric Cancer: A Case Report.Eculizumab in secondary atypical haemolytic uraemic syndrome.Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome: A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature.Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Anticancer Drug-Induced Acute Kidney Injury.ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome.Thrombotic Microangiopathy and the Kidney.Effect of high salt diet on blood pressure and renal damage during vascular endothelial growth factor inhibition with sunitinib.Melt electrospinning of daunorubicin hydrochloride-loaded poly (ε-caprolactone) fibrous membrane for tumor therapy.
P2860
Q30251919-37C5B77B-426A-4AC2-A841-085C0B25225DQ33441312-3CDE6DFD-AE13-4F94-AB41-D79700303230Q33620588-0FDF4D34-8B4C-4D6F-9C3C-C1F52A8C9496Q33705135-6AC7BF12-F71B-4820-A50D-391FE57E3FECQ38827793-6E10D9EF-4793-4C2A-B193-AED80B08729DQ39309248-BE0F9991-9121-4198-9284-53431FB3099CQ41041480-B0E53ED3-BB9A-4986-A53D-A37FC7EB6858Q42086661-994A51BB-D363-4ED6-BA20-8DBF6FDF052CQ47261056-EF044E86-36B9-41E7-A75C-42D4DE39019CQ47630342-C08891BE-0735-4C0E-B14C-862BC7358FBCQ48146844-9A0BBC1C-F628-4117-A774-0800C22196A3Q50085453-200C99F8-B8E6-4B2F-9F94-D9E0C24BB5A2Q53239742-1FB50B98-6C38-42EF-923F-E22D8015EC8CQ55387579-EAE3BF7C-C617-4FED-8FA9-D8AA31D9AC9D
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Thrombotic microangiopathy, cancer, and cancer drugs.
@ast
Thrombotic microangiopathy, cancer, and cancer drugs.
@en
type
label
Thrombotic microangiopathy, cancer, and cancer drugs.
@ast
Thrombotic microangiopathy, cancer, and cancer drugs.
@en
prefLabel
Thrombotic microangiopathy, cancer, and cancer drugs.
@ast
Thrombotic microangiopathy, cancer, and cancer drugs.
@en
P1476
Thrombotic microangiopathy, cancer, and cancer drugs.
@en
P2093
Hassan Izzedine
Mark A Perazella
P304
P356
10.1053/J.AJKD.2015.02.340
P577
2015-05-02T00:00:00Z